QurAlis Reveals Newest Program Targeting UNC13A RNA Mis-splicing Incorporating its FlexASO™ Platform ...Middle East

UNC13A is an essential regulator of neurotransmitter release at synapses; genetic alteration of UNC13A caused by mis-splicing occurs in 58 percent of all ALS patients and up to half of all frontotemporal dementia cases QurAlis' therapeutic approach utilizing the FlexASO™ Splice Modulator...

Hence then, the article about quralis reveals newest program targeting unc13a rna mis splicing incorporating its flexaso platform was published today ( Monday 20/03/2023 - 12:24 PM ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( QurAlis Reveals Newest Program Targeting UNC13A RNA Mis-splicing Incorporating its FlexASO™ Platform )

Also on site :

• With Just Two Looks, Taylor Russell Is Already In the Running for Best-Dressed at Cannes
• US Supreme Court’s uneven rulings in election lead-up causing chaos, experts say
• US extends Russian oil waiver – media